Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6666)
All Articles published online
|
Publishing Process of This Article
|
Jul 15, 2014 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lea MA, Pourat J, Patel R, desBordes C. Growth inhibition of colon cancer cells by compounds affecting AMPK activity. World J Gastrointest Oncol 2014; 6(7): 244-252 [PMID: 25024815 DOI: 10.4251/wjgo.v6.i7.244] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v6/i7/244.htm |
| Number | Citing Articles |
| 1 |
Ji-Ye Kee, Yo-Han Han, Jeong-Geon Mun, Seong-Hwan Park, Hee D. Jeon, Seung-Heon Hong. Gomisin A Suppresses Colorectal Lung Metastasis by Inducing AMPK/p38-Mediated Apoptosis and Decreasing Metastatic Abilities of Colorectal Cancer Cells. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00986
|
| 2 |
Su Han, Xue-Li Zhang, Xu Jiang, Xiang Li, Jian Ding, Li-Jiao Zuo, Shan-Shan Duan, Rui Chen, Bei-Bei Sun, Xin-Yi Hu, Yan-Nan Gao, Xiao-Li Zhang. Long Non-Coding RNA and mRNA Expression Analysis in Liver of Mice With Clonorchis sinensis Infection. Frontiers in Cellular and Infection Microbiology 2022; 11 doi: 10.3389/fcimb.2021.754224
|
| 3 |
Hailong Li, Yue Chen, Lei Hu, Wenzhi Yang, Zongshi Gao, Mengqing Liu, Hui Tao, Jie Li. Will metformin use lead to a decreased risk of thyroid cancer? A systematic review and meta-analyses. European Journal of Medical Research 2023; 28(1) doi: 10.1186/s40001-023-01287-0
|
| 4 |
Zheyu Zhang, Sifang Zhang, Jingjing Yang, Pengji Yi, Panpan Xu, Min Yi, Weijun Peng. Integrated transcriptomic and metabolomic analyses to characterize the anti-cancer effects of (−)-epigallocatechin-3-gallate in human colon cancer cells. Toxicology and Applied Pharmacology 2020; 401: 115100 doi: 10.1016/j.taap.2020.115100
|
| 5 |
Giorgia Zadra, Julie L. Batista, Massimo Loda. Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies. Molecular Cancer Research 2015; 13(7): 1059 doi: 10.1158/1541-7786.MCR-15-0068
|
| 6 |
Wei Yang, Yingjun Li, Yong Ai, Obinna N. Obianom, Dong Guo, Hong Yang, Srilatha Sakamuru, Menghang Xia, Yan Shu, Fengtian Xue. Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation. Journal of Medicinal Chemistry 2019; 62(24): 11151 doi: 10.1021/acs.jmedchem.9b01252
|
| 7 |
Dexuan Zhuang, Shuangshuang Wang, Guanyi Liu, Panpan Liu, Huiting Deng, Jianfeng Sun, Chang Liu, Xue Leng, Qun Zhang, Fuxiang Bai, Jun Mi, Xunwei Wu. Phenformin suppresses angiogenesis through the regulation of exosomal microRNA-1246 and microRNA-205 levels derived from oral squamous cell carcinoma cells. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.943477
|
| 8 |
M Michailidou, IN Melas, DE Messinis, S Klamt, LG Alexopoulos, FN Kolisis, H Loutrari. Network-Based Analysis of Nutraceuticals in Human Hepatocellular Carcinomas Reveals Mechanisms of Chemopreventive Action. CPT: Pharmacometrics & Systems Pharmacology 2015; 4(6): 350 doi: 10.1002/psp4.40
|
| 9 |
Baiyu Han, Hanzhi Cui, Lei Kang, Xuelin Zhang, Zhitao Jin, Lanmin Lu, Zhongyi Fan. Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway. Tumor Biology 2015; 36(8): 6295 doi: 10.1007/s13277-015-3315-4
|
| 10 |
Peng-Nian Yew, Yau-Yan Lim, Wai-Leng Lee. Tannic acid-rich porcupine bezoars induce apoptosis and cell cycle arrest in human colon cancer cells. Pharmacognosy Magazine 2019; 15(65): 523 doi: 10.4103/pm.pm_620_18
|
| 11 |
A. Carlson, K. S. Alderete, M. K. O. Grant, D. M. Seelig, L. C. Sharkey, B. N. M. Zordoky. Anticancer effects of resveratrol in canine hemangiosarcoma cell lines. Veterinary and Comparative Oncology 2018; 16(2): 253 doi: 10.1111/vco.12375
|
| 12 |
Yang Li, Dan Wang, Hui Ren, Wei Feng. Metformin alleviates breast cancer through targeting high‐mobility group AT‐hook 2. Thoracic Cancer 2020; 11(3): 686 doi: 10.1111/1759-7714.13318
|
| 13 |
Da-Yan Zhou, Yong Su, Pan Gao, Qi-Hong Yang, Zhe Wang, Qiang Xu. Resveratrol ameliorates high glucose-induced oxidative stress injury in human umbilical vein endothelial cells by activating AMPK. Life Sciences 2015; 136: 94 doi: 10.1016/j.lfs.2015.07.008
|
| 14 |
Changwei Liu, Penghui Li, Zhihao Qu, Wei Xiong, Ailing Liu, Sheng Zhang. Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors. Molecules 2019; 24(9): 1726 doi: 10.3390/molecules24091726
|
| 15 |
Tharinee Mattaveewong, Preedajit Wongkrasant, Sumalee Chanchai, Rath Pichyangkura, Varanuj Chatsudthipong, Chatchai Muanprasat. Chitosan oligosaccharide suppresses tumor progression in a mouse model of colitis-associated colorectal cancer through AMPK activation and suppression of NF-κB and mTOR signaling. Carbohydrate Polymers 2016; 145: 30 doi: 10.1016/j.carbpol.2016.02.077
|
| 16 |
Rajneet Kaur Khurana, Arvind K. Bansal, Sarwar Beg, Andrea Julie Burrow, O.P. Katare, Kamalinder K. Singh, Bhupinder Singh. Enhancing biopharmaceutical attributes of phospholipid complex-loaded nanostructured lipidic carriers of mangiferin: Systematic development, characterization and evaluation. International Journal of Pharmaceutics 2017; 518(1-2): 289 doi: 10.1016/j.ijpharm.2016.12.044
|
| 17 |
Eman Awad, Eman Othman, Helga Stopper. Effects of Resveratrol, Lovastatin and the mTOR-Inhibitor RAD-001 on Insulin-Induced Genomic Damage In Vitro. Molecules 2017; 22(12): 2207 doi: 10.3390/molecules22122207
|
| 18 |
Xuexue Zhu, Yuetao Zhou, Weiwei Cai, Haijian Sun, Liying Qiu. Salusin-β mediates high glucose-induced endothelial injury via disruption of AMPK signaling pathway. Biochemical and Biophysical Research Communications 2017; 491(2): 515 doi: 10.1016/j.bbrc.2017.06.126
|
| 19 |
Si Hyoung Kim, Jun Goo Kang, Chul Sik Kim, Sung-Hee Ihm, Moon Gi Choi, Hyung Joon Yoo, Seong Jin Lee. Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells. Endocrine 2018; 59(2): 383 doi: 10.1007/s12020-017-1503-2
|
| 20 |
Ji‐Hye Park, Young‐heon Kim, Eun Hyeh Park, Sun‐Joo Lee, Hyewon Kim, Areumnuri Kim, Seung Bum Lee, Sehwan Shim, Hyosun Jang, Jae Kyung Myung, Sunhoo Park, Su‐Jae Lee, Min Jung Kim. Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer. Cancer Science 2019; 110(9): 2834 doi: 10.1111/cas.14124
|